Exponent (EXPO) Q3 2024 earnings summary

Executive summary

• Net income grew 6% to $26.0M in Q3 2024, with EBITDA margin expanding by 100 basis points and stable revenues before reimbursements year-over-year.

• Total revenues increased 2% to $136.3M, driven by growth in consumer electronics and utilities, offset by headwinds in chemicals and tough comps in reactive services.

• Utilization improved to 73% (from 70%), while technical FTEs decreased 10% to 949; billable hours fell 5%.

• Maintained strong market position in failure analysis and complex regulatory consulting, supporting long-term growth.

• Diversified portfolio provided stability amid dynamic market conditions.

Financial highlights

• Q3 2024 revenues: $136.3M (+2% YoY); net revenues flat at $125.1M; net income: $26.0M ($0.50/diluted share); EBITDA: $35.8M (28.6% margin).

• Operating income for Q3: $25.8M; gross margin: 19.4%; consolidated tax rate: 27.5%.

• Cash and equivalents at period end: $219.7M; $44.0M in dividends paid YTD.

• G&A expenses declined 12% to $5.3M; capital expenditures were $1.7M; $14.2M distributed as dividends in Q3.

• Cash flow from operations for nine months: $88.5M; capital expenditures: $4.3M.

Outlook and guidance

• Q4 2024: Net revenues expected to grow mid-single digits; EBITDA margin 23.5%-24.5%.

• FY 2024: Net revenues to grow low to mid-single digits; EBITDA margin raised to 27.9%-28.1%.

• Sequential headcount growth of 1%-2% per quarter expected in 2025; utilization target remains mid-70s%.

• Stock-based compensation for FY 2024 expected at $23.2M-$23.4M; G&A expense at $23.2M-$23.7M.

• Management expects continued investment in talent and infrastructure, with a focus on expanding market position.